SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 863.93 |
| Enterprise Value ($M) | 760.03 |
| Book Value ($M) | 362.29 |
| Book Value / Share | 6.85 |
| Price / Book | 2.38 |
| NCAV ($M) | 347.31 |
| NCAV / Share | 6.57 |
| Price / NCAV | 2.49 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.23 |
| Return on Assets (ROA) | -0.35 |
| Return on Equity (ROE) | -0.38 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 29.55 |
| Current Ratio | 29.55 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 365.61 |
| Assets | 380.59 |
| Liabilities | 18.30 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Nextech Vi Oncology Scsp | 7.70 | 61.04 | |
| 13G/A | Biotechnology Value Fund L P | 8.80 | 70.14 | |
| 13D/A | Ra Capital Management, L.p. | 21.10 | 5.81 | |
| 13G/A | Fmr Llc | 6.39 | -27.53 | |
| 13D/A | Boxer Capital Management, LLC | 9.90 | ||
| 13D/A | Boxer Asset Management Inc. | 0.00 | ||
| 13D/A | Boxer Capital, LLC | 12.40 | 1.33 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| l UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| l UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 100,040 | 700,264 | 14.29 | |
| 67,518 | 241,846 | 27.92 | |
| 49,186 | 246,121 | 19.98 | |
| 122,399 | 303,713 | 40.30 | |
| 21,094 | 140,643 | 15.00 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TSVT – 2seventy bio, Inc. | TWST – Twist Bioscience Corporation |
| TXMD – TherapeuticsMD, Inc. | UBX – Unity Biotechnology, Inc. |
| UTHR – United Therapeutics Corporation |
Financial data and stock pages provided by
Fintel.io